Product Information
MIRTAZAPINE 30 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0869 per EA under NDC 00378353093. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 19, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378353093
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076122FDA Approved
6/19/2003
TE Code
AB
On Market Since
6/20/2003
Price Statistics
The NADAC for MIRTAZAPINE 30 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 38.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0869 per EA |
|---|---|
| All-time high | $0.2592 (Aug 13, 2014) |
| All-time low | $0.0716 (Nov 20, 2024) |
| 52-week high | $0.0914 |
| 52-week low | $0.0858 |
| Median price | $0.1106 |
| Average price | $0.1241 |
| Largest weekly change | +24.5% (Dec 23, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 30 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0869 per EA (NDC 00378353093), effective Aug 19, 2026.
How has the price of MIRTAZAPINE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 30 MG TABLET has declined 38.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 30 MG TABLET?
Since Nov 28, 2013, the NADAC for MIRTAZAPINE 30 MG TABLET has ranged from a low of $0.0716 (Nov 20, 2024) to a high of $0.2592 (Aug 13, 2014), with a median of $0.1106 per EA.
Are there cheaper alternatives to MIRTAZAPINE 30 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIRTAZAPINE 30 MG TABLET, is $0.0723 per EA — about 17% below MIRTAZAPINE 30 MG TABLET.
Who manufactures MIRTAZAPINE 30 MG TABLET?
MIRTAZAPINE 30 MG TABLET (NDC 00378353093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.